Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRT-PC Trial
NCT07882862Phase 2Not yet recruiting
- Sponsor
- University of Nebraska
- Start
- Jan 2027
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Phase 2, open-label trial of clomiphene in Hypogonadism (2 cohorts), sponsored by University of Nebraska. Primary endpoint: Proportion of participants with eugonadal serum testosterone (>= 300 ng/dL) at 6 months. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
clomiphene
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT07882862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07882862.